Meeting to set up the BUBOLight® clinical trial

The meeting to set up the pilot, monocentric, descriptive, feasibility, safety and tolerance study of the BUBOLight® device "took place on September 14 at the Jeanne de Flandre Maternity Unit of the Lille University Hospital

 Actualité 15 Sept 2020 1

BUBOLight®, is a new phototherapy device for the treatment of jaundice in newborns. The study will be carried out under the responsibility of Dr Thameur RAKZA, Head of the Maternity Unit. This device was designed at OncoThAI with financial support from the operational program, 2014 - 2020, Nord - Pas de Calais, CCI: 2014FR16M0OP012

 Actualité 15 Sept 2020 2